Questa traduzione è in preparazione. Nel frattempo mostriamo temporaneamente la versione originale in inglese.
Imprese · 29/08/20061 min di lettura
Cardiovascular and Renal Drugs Advisory Committee; Amendment of Notice
Traduzione automatica locale · Lingua originale della fonte
Riepilogo
The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Cardiovascular and Renal Drugs Advisory Committee. This meeting was originally announced in the Federal Register of August 1, 2006 (71 FR 43487). The amendment is being made to reflect changes in the Agenda portion of the document. The word "TRASYOL" should read "TRASYLOL". In the same paragraph, the word "apportioning" should read "aprotinin". There are no other changes.
Lingua originale della fonte: Federal Register — Food and Drug AdministrationApri il comunicato originale →